五酯胶囊对他克莫司药代动力学的影响

米丽, 位华, 李敬超, 秦士新, 茅建辉

武警医学 ›› 2016, Vol. 27 ›› Issue (3) : 240-242.

PDF(650 KB)
PDF(650 KB)
武警医学 ›› 2016, Vol. 27 ›› Issue (3) : 240-242.
论著

五酯胶囊对他克莫司药代动力学的影响

  • 米丽1, 位华2, 李敬超3, 秦士新4, 茅建辉1
作者信息 +

Effect of Wuzhi capsules on pharmacokinetics of tacrolimus

  • MI Li1,WEI Hua2, LI Jingchao3, QIN Shixin4, and MAO Jianhui1
Author information +
文章历史 +

摘要

目的 观察不同剂量五酯胶囊对他克莫司药代动力学的影响。方法 40名健康志愿者,随机分为5组,在口服给药2 mg 他克莫司5 min后,分别给予0、1、2、6及8粒五酯胶囊,于给药前、给药后不同时间点静脉取血,置于抗凝管中,保存至分析测定。结果 他克莫司的药物动力学参数AUC0→t、Tmax随着五酯胶囊剂量的增大而增大,最大时分别可达到(459.3±114.2)ng/(h·ml)和(3.125±1.356)h,而Cmax则在五酯胶囊服用2粒时最大,达(43.539±10.656)ng/ml。口服清除率 (CL/F ratio), 1粒五酯胶囊时,就降至到51.67%,当服用8粒时,降至到27.09%。结论 合用五酯胶囊后,他克莫司在体内代谢速度减慢,清除率降低,血药浓度升高。

Abstract

Objective To evaluate the effect of different doses of Wuzhi capsules on the pharmacokinatics of Tacrolimus in healthy human body. Methods 40 healthy volunteers were divided into 5 groups, and 0, 1, 2, 6, 8 capsules of Wuzhi capsules were given to each group accordingly after 2 mg of tacrolimus was given systematically. Venous blood was collected before and at different time points after drug administration. Blood samples were collected in anti-coagulation tubes and stored till analysis. Results The dose of tacrolimus was increased with the increase of the dose of Wuzhi capsules AUC0→t, Tmax, and the largest were (459.3±114.2)ng·h/ml and(3.125±1.356)h, respectively, and Cmax was the largest after taking two capsules (43.539±10.656) ng/ml. The CL/F ratio decreased from 51.67% to 27.09% when the dose of Wuzhi capsules increased from 1 capsule to 8 capsules. Conclusions The metabolic rate of tacrolimus decreases, the clearance rate decreases and the blood concentration increases when Wuzhi capsules are administered together with tacrolimus.

关键词

他克莫司 / 五酯胶囊 / 药动学 / 高效液相色谱法

Key words

Tacrolimus / Wuzhi capsules / pharmacokinetics / HPLC

引用本文

导出引用
米丽, 位华, 李敬超, 秦士新, 茅建辉. 五酯胶囊对他克莫司药代动力学的影响[J]. 武警医学. 2016, 27(3): 240-242
MI Li,WEI Hua, LI Jingchao, QIN Shixin, and MAO Jianhui. Effect of Wuzhi capsules on pharmacokinetics of tacrolimus[J]. Medical Journal of the Chinese People Armed Police Forces. 2016, 27(3): 240-242
中图分类号: R978    R657.3   

参考文献

[1]陈 超,邬义强,林述龙.五酯胶囊联合西药治疗慢性乙型肝炎42例疗效观察[J].云南中医中药杂志,2008, 29(11):23-24.
[2] Anglicheau D, Legendre C, Beanne P, et al. Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update[J].Pharmacogenomics,2007,8(7):835-849.
[3] MacPhee I A, Holt D W. A. pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype [J]. Transplantation, 2008, 85(2):163-165.
[4] 刘丽娟,赖雁威,李慧云,等. 肝移植患者他克莫司谷血药浓度监测意义和临床个体化用药调节[J]. 现代生物医学进展,2015,25(12):1026-1030.
[5] Park J Y, Shin H K,Choi Y W,et al. Gomisin A induces Ca2+-dependent activation of eNOS in human coronary artery endothelial cells [J]. J Ethnopharmaco1, 2009, 125(2):291-296.
[6] 徐艳霞.中草药对肝细胞色素P450的作用[J].中国药理通讯,2005,22(3):64-68.

PDF(650 KB)

Accesses

Citation

Detail

段落导航
相关文章

/